This paper lays out a approach for safety assurance case argumentation. The approach links together in a principled manner a device's highest-level safety claims, operating environments and hazards; and its safety requirements, final implementation, and test and other validation results. This approach is intended for the creation of safety assurance cases for pre-market submissions to a regulatory authority like the Food and Drug Administration.
No takes yet. Share an insight, caveat, or question.
Ray et al. (2013) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: